The European Society of Clinical Microbiology and Infectious Diseases 34th Congress (ESCMID Global 2024)

Barcelona, Spain 27 April 2024 - 30 April 2024

Gepotidacin as good as current standard treatment for urogenital gonorrhoea

24 May 2024 bởi

The oral investigational antibiotic gepotidacin is noninferior to the current standard treatment for uncomplicated urogenital gonorrhoea in the randomized, multicentre, phase III EAGLE-1 trial.

Gepotidacin as good as current standard treatment for urogenital gonorrhoea

24 May 2024

Dalbavancin shows promise for complicated SAB management

21 May 2024 bởi

Findings from the DOTS trial presented at ESCMID Global 2024 underpin the potential of dalbavancin, a long-acting lipoglycopeptide, for the management of complicated Staphylococcus (S.) aureus bacteraemia (SAB) without requiring long-term vascular access.

Dalbavancin shows promise for complicated SAB management

21 May 2024

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024 bởi

Prophylactic interferon-alpha (IFN-α) administered intranasally slashed the incidence of COVID-19 by almost half in a cohort of cancer patients in the C-SMART study.

Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients

20 May 2024

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

14 May 2024 bởi

Sequential treatment with the oral antibiotic fosfomycin appears to be safe and effective in the management of patients with acute bacterial prostatitis secondary to multidrug-resistant Escherichia coli, according to the phase IV FOS-PROST study.

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

14 May 2024

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

14 May 2024 bởi

Patients with positive in-vitro antibiotic interactions with vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia appear to have greater survival at 2 weeks, as shown in a post hoc analysis of the CAMERA-2* study.

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

14 May 2024

RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults

13 May 2024 bởi

Coadministration of mRNA-1345, a respiratory syncytial virus (RSV) vaccine, with an influenza (flu) or a COVID-19 vaccine in older adults exhibits good tolerability and has an acceptable reactogenicity profile, according to a US study presented at ESCMID Global Congress 2024.

RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults

13 May 2024

Ceftobiprole as good as daptomycin in achieving S. aureus bloodstream clearance

13 May 2024 bởi

Ceftobiprole was as effective as daptomycin in achieving bloodstream clearance in patients with complicated Staphylococcus aureus (S. aureus) bacteremia, according to the ERADICATE study presented at ESCMID 2024.

Ceftobiprole as good as daptomycin in achieving S. aureus bloodstream clearance

13 May 2024

Aztreonam-avibactam cracks into hard-to-treat MBL-producing MDR-GNB

13 May 2024 bởi

The fixed-dose combination of aztreonam and avibactam yields a 41.7-percent clinical cure rate in serious infections caused by metallo-β-lactamase (MBL)–producing multidrug-resistant (MDR) Gram-negative bacteria (GNB), according to the results from the phase III ASSEMBLE trial.

Aztreonam-avibactam cracks into hard-to-treat MBL-producing MDR-GNB

13 May 2024

Antibiotic ‘breathalyzer’ a promising alternative for therapeutic drug monitoring

12 May 2024 bởi

Analysis of exhaled breath may be able to identify the presence of specific metabolites for four out of five antibiotics, offering a noninvasive approach to performing therapeutic drug monitoring.

Antibiotic ‘breathalyzer’ a promising alternative for therapeutic drug monitoring

12 May 2024

Zoliflodacin noninferior to dual therapy for uncomplicated urogenital gonorrhoea

11 May 2024 bởi

Zoliflodacin was noninferior to ceftriaxone plus azithromycin in achieving microbiological cure at the urogenital site in patients with uncomplicated gonorrhoea, according to a study presented at ESCMID 2024.

Zoliflodacin noninferior to dual therapy for uncomplicated urogenital gonorrhoea

11 May 2024